By adding a magnetic field to the tumor area, the obtained magnetic targeting procoagulant protein (MTPCP) could be quickly enriched in the tumor vessels and further bound to NRP-1 of TVEC by EG3287, resulting in the selective generation of coagulation in tumor-associated blood vessels. The gene discussed is NRP1; the disease is neoplasm.